✉news BusinessRetail first seen 7 h ago, last 38 min ago, peak #16
Retail Traders Eye SLS and IBRX After Moderna Joins Nasdaq-100
Original: SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Retail traders are speculating that Sellas Life Sciences (SLS) and ImmunityBio (IBRX) could be the next biotech stocks to gain a Nasdaq-100 inclusion after Moderna (MRNA) landed a spot in the index. Some investors are voicing confidence that SLS will follow, fueling chatter and speculative buying around the smaller biotech names.
Why now: Index inclusion typically drives fund inflows and share price gains, so traders are betting on which stock could be added next.
SLS (Sellas Life Sciences)ImmunityBio (IBRX)Moderna (MRNA)Nasdaq-100
Rank over time, top of the chart is #1. 6 snapshots from 7 h ago to 38 min ago.
Evidence
- SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’ · Stocktwits
API: https://socialmediatrends-api.osmike.com/v1/trends/928514